Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5
Original Research
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,693 | Dovepress* | 5,211+ | 1,009 | 6,220 | |
| PubMed Central* | 482 | 111 | 593 | ||
| Totals | 5,693 | 1,120 | 6,813 | ||
| *Since 12 January 2018 | |||||
View citations on PubMed Central and Google Scholar